"If everybody's on Ozempic, there won't be enough humans in the world to alter those dresses." This bridal shop owner has already seen how Ozempic and GLP-1 drugs can dramatically 'alter' wedding dresses. Watch The Ozempic Effect: Beyond the Waistline on CBC Gem.
NEW YORK — Nora Nye, 58, is refreshing her wardrobe as she sizes down for the first time in over three decades after losing 80 pounds on weight-loss drug Mounjaro. Earlier this year, the Denver bankruptcy lawyer walked into a Macy's and found herself overwhelmed.
Nora Nye poses for a portrait in a new outfit she purchased after losing weight while on the GLP-1 medication Mounjaro, July 27 at her home in Denver, Colo.
Nora Nye poses for a portrait in a new outfit she purchased after losing weight while on the GLP-1 medication Mounjaro, July 27 at her home in Denver, Colo.
A new analysis is raising safety concerns about Wegovy, the blockbuster GLP-1 weight-loss drug, after researchers found it may carry the highest risk among similar medications of a rare condition called nonarteritic anterior ischemic optic neuropathy — sometimes called an "eye stroke" — that can cause sudden, permanent vision loss. The finding adds to a growing list of questions surrounding long-term GLP-1 safety even as millions of Americans use these drugs for weight loss and diabetes. Researchers say patients experiencing sudden vision changes should seek emergency care immediately. Disclosure: This video contains stock footage and content created or enhanced using AI-assisted tools. WooGlobe Ref : WGA126542
Nora Nye poses for a portrait in a new outfit she purchased after losing weight while on the GLP-1 medication Mounjaro, July 27 at her home in Denver, Colo.
Nora Nye poses for a portrait in a new outfit she purchased after losing weight while on the GLP-1 medication Mounjaro, July 27 at her home in Denver, Colo.
